基于生物标志物的适应性设计用于早期临床试验
Alessandra Serra1, Gaëlle Saint-Hilary2, Sandrine Guilleminot3
1University of Cambridge, MRC Biostatistics Unit, Cambridge, UK.
Statistics in medicine
|October 9, 2025
概括
这项研究引入了生物标志物指导的临床试验设计,用于早期瘤学研究. 适应性方法通过根据预测生物标志物精细化患者群体来改善决策,即使样本规模有限.
科学领域:
- 临床试验的设计
- 发现生物标志物的发现.
- 瘤学研究的研究.
背景情况:
- 精准医学依赖于确定患者分层的预测生物标志物.
- 早期适应性试验设计通过试验中的修改来提高效率.
- 目前的设计可能会错过生物标志物定义的子组中的疗效信号.
研究的目的:
- 提出一种新的单臂,两阶段,早期生物标志物引导的设计.
- 为了使适应性决策能够在临时分析中进行人口提炼.
- 为了提高生物标志物子组的有效性信号检测.
主要方法:
- 开发一个双阶段,单臂自适应设计.
- 纳入为人口选择/丰富的中间分析.
- 模拟研究用于评估设计性能.
主要成果:
- 拟议的生物标志物导向设计可以提高早期试验阶段的决策能力.
- 它与缺乏生物标记物丰富的经典设计相比,具有优势.
- 即使在有限的样本大小下也是有效的,它有助于识别疗效信号.
结论:
- 生物标志物引导的适应性设计对于早期瘤学试验非常有价值.
- 这种方法优化了患者的选择,并提高了检测疗效信号的机会.
- 它代表了以患者为中心的临床开发的重大进步.
相关概念视频
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Bioavailability Study Design: Healthy Subjects Versus Patients
126
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
126
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
375
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
375
Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K


